Therapeutic drug monitoring of vancomycin by AUCτ-MIC ratio in patients with chronic kidney disease

Therapeutic drug monitoring of vancomycin by AUCτ-MIC ratio in patients with chronic kidney disease

In this study which was conducted in Alzahra University Hospital (Isfahan, I.R. Iran), the therapeutic drug monitoring of vancomycin focused on determining area under the concentration-time curve at dosing interval (τ) at steady state/minimum inhibitory concentration (AUCτ/MIC) was carried out in ch...

Full description

Bibliographic Details
Main Authors:	Ahmad Khoei, Rasool Soltani, Jaber Emami, Shirinsadat Badri, Shahram Taheri
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2019-01-01
Series:	Research in Pharmaceutical Sciences
Subjects:	aucτ/mic; chronic kidney disease; therapeutic drug monitoring; vancomycin.
Online Access:	http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2019;volume=14;issue=1;spage=84;epage=92;aulast=Khoei

Similar Items

A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
by: Wasan Katip, et al.
Published: (2021-08-01)

Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible
by: Kashif Hussain, et al.
Published: (2022-08-01)

Evaluation of the Association between Trough and Area Under the Curve to Minimum Inhibitory Concentration Ratio (AUC24/MIC) of Vancomycin in Infected Patients with Methicillin Resistant Staphylococcus aureus (MRSA)
by: Ayda Esmaeili, et al.
Published: (2021-06-01)

Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus
by: Seenae Eum, et al.
Published: (2016-09-01)

Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets
by: Nicole Bradley, et al.
Published: (2023-06-01)

Association of vancomycin trough concentration on the treatment outcome of patients with bacteremia caused by Enterococcus species
by: Yujin Sohn, et al.
Published: (2021-10-01)

Vancomycin AUC-Based Dosing Practices in a Non-Teaching Community Hospital and Associated Outcomes: A One-Year Survey of Uniform Targets for Infections with or without MRSA
by: Iftekharul Islam
Published: (2024-01-01)

Pharmacokinetic/pharmacodynamic parameters of vancomycin for predicting clinical outcome of enterococcal bacteremia
by: Eliel Nham, et al.
Published: (2022-08-01)

Characteristics and calculations of paired vancomycin measurements for determination of 24-h area-under-curve (AUC)
by: Yutao Deng, et al.
Published: (2023-03-01)

Occurrence of vancomycin MIC creep in methicillin resistant isolates in Saudi Arabia
by: Sameerah Aljohani, et al.
Published: (2020-10-01)

Treatment of Intracranial Infection Caused by Methicillin-Resistant Staphylococcus epidermidis with Linezolid Following Poor Outcome of Vancomycin Therapy: A Case Report and Literature Review
by: Fu X, et al.
Published: (2021-07-01)

Association between single trough-based area under the curve estimation of vancomycin and treatment outcome among methicillin-resistant Staphylococcus aureus bacteremia patients
by: Mohd Makmor-Bakry, et al.
Published: (2019-08-01)

Evaluation of polymyxin B AUC/MIC ratio for dose optimization in patients with carbapenem-resistant Klebsiella pneumoniae infection
by: Peile Wang, et al.
Published: (2023-08-01)

Vancomycin Area under the Concentration-Time Curve Estimation Using Bayesian Modeling versus First-Order Pharmacokinetic Equations: A Quasi-Experimental Study
by: Yazed Saleh Alsowaida, et al.
Published: (2022-09-01)

Predicting Antibiotic Effect of Vancomycin Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation: Dense Sampling versus Sparse Sampling
by: Yong Kyun Kim, et al.
Published: (2022-05-01)

Candidates for area under the concentration–time curve (AUC)-guided dosing and risk reduction based on analyses of risk factors associated with nephrotoxicity in vancomycin-treated patients
by: Naoto Hashimoto, et al.
Published: (2021-12-01)

τ-metrizable spaces
by: A.C. Megaritis
Published: (2018-10-01)

Vitamin E in the prevention of vancomycin-induced nephrotoxicity
by: Rasool Soltani, et al.
Published: (2020-01-01)

Effect of different sub MIC concentrations of penicillin, vancomycin and ceftazidime on morphology and some biochemical properties of Staphylococcus aureus and Pseudomonas aeruginosa isolates
by: Bahram Amini, et al.
Published: (2009-03-01)

The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing
by: Moeko Tsutsuura, et al.
Published: (2021-02-01)

Decreased vancomycin MICs among methicillin-resistant Staphylococcus aureus clinical isolates at a Chinese tertiary hospital over a 12-year period
by: Chaohui Lu, et al.
Published: (2016-10-01)

Partial AUC maximization for essential gene prediction using genetic algorithms
by: Kyu-Baek Hwang, et al.
Published: (2013-01-01)

On τ [M ]-Cohereditary Modules
by: S Suprapto, et al.
Published: (2011-07-01)

Preliminary notice: 11th Arctic Ungulate Conference (AUC)
by: Rolf Egil Haugerud (ed.)
Published: (2002-06-01)

The First Arctic Ungulate Conference (AUC) 1991
by: Sven Skjenneberg (ed.)
Published: (1991-10-01)

The Synergism Effect Of Cefepime And Vancomycin Against Coagulse Positive And Negative Methiciline Resistant Staphylococci
by: Curus Azimi, et al.
Published: (2012-10-01)

The Synergism Effect Of Cefepime And Vancomycin Against Coagulse Positive And Negative Methiciline Resistant Staphylococci
by: Hossein Dargahi, et al.
Published: (2012-07-01)

Evaluation of traditional initial vancomycin dosing versus utilizing an electronic AUC/MIC dosing program
by: Kerri A. McGrady, et al.
Published: (2020-09-01)

<b>On α- τ-disconnectedness and α- τ-connectedness in topological spaces
by: Sanjay Mishra
Published: (2015-07-01)

A novel estimator for the two-way partial AUC
by: Elias Chaibub Neto, et al.
Published: (2024-02-01)

Pharmacokinetics and Pharmacodynamics of Florfenicol in Plasma and Synovial Fluid of Pigs at a Dose of 30 mg/kg<sub>bw</sub> Following Intramuscular Administration
by: Zoltán Somogyi, et al.
Published: (2023-04-01)

Synovial and Systemic Pharmacokinetics of Florfenicol and PK/PD Integration against <i>Streptococcus suis</i> in Pigs
by: Zoltán Somogyi, et al.
Published: (2022-01-01)

A simple and validated HPLC method for vancomycin assay in plasma samples: the necessity of TDM center development in Southern Iran
by: Parisa Ghasemiyeh, et al.
Published: (2020-01-01)

Τ-quasi-Cauchy spaces - a non-symmetric theory of completeness and completion
by: Gunther Jäger
Published: (2023-04-01)

The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients
by: Jihui Chen, et al.
Published: (2021-12-01)

Relationship Between Docetaxel AUC and Neutropenia in Patients with Breast Cancer
by: ZHANG Ni, et al.
Published: (2018-05-01)

Critical assessment of the revised guidelines for vancomycin therapeutic drug monitoring
by: Abdullah Aljutayli, et al.
Published: (2022-11-01)

Influence of partially τ-embedded subgroups of prime power order in supersolubility and p-nilpotency of finite groups
by: Lian Chen, et al.
Published: (2019-12-01)

Programme and abstracts - the 11th Arctic Ungulate Conference (AUC), 24-28 August 2003, Saariselkä, Finland
by: Rolf Egil Haugerud (Editor)
Published: (2003-04-01)

Automated Susceptibility Testing With Vitek 2 Compared to MicroScan Reduces Vancomycin Alternative Therapy For Methicillin-Resistant Staphylococcus Aureus Bacteremia
by: Dusten T. Rose, et al.
Published: (2022-04-01)